Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rolling review: gastrointestinal malignancy

G D Luk1

  • 1Department of Veterans Affairs Medical Center, Dallas, TX 75216.

Alimentary Pharmacology & Therapeutics
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of structural equation modeling to test the construct validity of a case definition of Gulf War syndrome: invariance over developmental and validation samples, service branches and publicity.

Psychiatry research·2001
Same author

Effect of spermine administration on pancreatic maturation in unweaned rats.

Comparative biochemistry and physiology. Part A, Molecular & integrative physiology·1998
Same author

Early weaning induces jejunal ornithine decarboxylase and cell proliferation in neonatal rats.

The Journal of nutrition·1998
Same author

Zollinger-Ellison syndrome, acromegaly, and colorectal neoplasia.

Journal of clinical gastroenterology·1997
Same author

Effect of thyroxine on pancreatic digestive enzymes and ornithine decarboxylase gene expression in neonatal rats.

Journal of pediatric gastroenterology and nutrition·1997
Same author

Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer.

Schweizerische medizinische Wochenschrift·1996
Same journal

Risk of Myeloproliferative Neoplasms in Patients With Inflammatory Bowel Disease and Impact on Outcomes: A Multi-Centre Matched Analysis.

Alimentary pharmacology & therapeutics·2026
Same journal

Biomarkers in Liver Transplantation for Hepatocellular Carcinoma: Towards Precision Medicine.

Alimentary pharmacology & therapeutics·2026
Same journal

Elobixibat Versus Prucalopride in Functional Constipation: A Prospective Comparative Effectiveness Study.

Alimentary pharmacology & therapeutics·2026
Same journal

A Distinct Immune Signature Characterizes Cirrhosis in Ethiopian Individuals With Chronic HBV Infection.

Alimentary pharmacology & therapeutics·2026
Same journal

Review Article: The Impact of the Gut Microbiome on Ulcerative Colitis Pharmacotherapy.

Alimentary pharmacology & therapeutics·2026
Same journal

Letter: Interpreting P-CAB Superiority for Antithrombotic Gastroprotection Beyond Acid Suppression. Authors' Reply.

Alimentary pharmacology & therapeutics·2026
See all related articles

Chemotherapy for gastrointestinal cancers is largely experimental, but some colorectal and anal cancer treatments are becoming standard. Understanding cancer biology, cell kinetics, and drug toxicity is crucial for effective treatment and managing side effects.

Area of Science:

  • Oncology
  • Gastroenterology
  • Pharmacology

Background:

  • Chemotherapy for gastrointestinal (GI) malignancies is primarily investigational.
  • Established adjuvant protocols exist for colorectal and anal cancers, serving as benchmarks for new regimens.
  • A foundational understanding of cancer biology, tumor cell kinetics, and drug toxicities is essential for appreciating chemotherapy regimens.

Purpose of the Study:

  • To highlight the current status of chemotherapy in GI malignancies.
  • To emphasize the importance of understanding cancer biology, cell kinetics, and drug toxicities.
  • To underscore the role of gastroenterologists in managing chemotherapy-induced toxicity within multidisciplinary teams.

Main Methods:

  • Literature review of current chemotherapy protocols for GI cancers.

Related Experiment Videos

  • Analysis of cancer biology, tumor cell kinetics, and drug toxicity principles.
  • Discussion of the gastroenterologist's role in managing treatment-related adverse events.

    • Main Results:

    • Chemotherapy for most GI cancers remains investigational.
    • Adjuvant chemotherapy for colorectal and anal cancers is increasingly standardized.
    • Knowledge of drug toxicities and their management is vital for clinical practice.

    Conclusions:

    • Gastroenterologists require a solid grasp of chemotherapy principles and toxicity management.
    • Active participation in multidisciplinary teams improves patient care for GI malignancies.
    • Understanding the nuances of chemotherapy enhances its application and management in GI oncology.